TRIT1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.03579994476166E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.03520000005464E-06 |
Normal-vs-Stage2 |
6.888100E-02 |
Normal-vs-Stage3 |
5.7695999977625E-08 |
Normal-vs-Stage4 |
3.68499999999772E-05 |
Stage1-vs-Stage2 |
3.685600E-01 |
Stage1-vs-Stage3 |
1.160640E-01 |
Stage1-vs-Stage4 |
2.906400E-01 |
Stage2-vs-Stage3 |
6.549800E-02 |
Stage2-vs-Stage4 |
1.492830E-01 |
Stage3-vs-Stage4 |
7.982000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
4.35570000067997E-08 |
Normal-vs-AfricanAmerican |
7.98820000000866E-05 |
Normal-vs-Asian |
5.142600E-03 |
Caucasian-vs-AfricanAmerican |
4.437000E-01 |
Caucasian-vs-Asian |
3.360500E-02 |
AfricanAmerican-vs-Asian |
4.760300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.75510000000045E-05 |
Normal-vs-Female |
4.43078906897654E-12 |
Male-vs-Female |
1.695040E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.672400E-01 |
Normal-vs-Age(41-60Yrs) |
9.84039999485375E-08 |
Normal-vs-Age(61-80Yrs) |
9.32470000103436E-08 |
Normal-vs-Age(81-100Yrs) |
1.770100E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.505630E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.521360E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.677000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.982000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.773000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.797600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
3.57490000046923E-07 |
Normal-vs-Grade 2 |
2.86469999943861E-08 |
Normal-vs-Grade 3 |
2.43789999999633E-05 |
Normal-vs-Grade 4 |
1.70648999999745E-05 |
Grade 1-vs-Grade 2 |
1.490190E-01 |
Grade 1-vs-Grade 3 |
8.544000E-02 |
Grade 1-vs-Grade 4 |
2.629800E-01 |
Grade 2-vs-Grade 3 |
3.031400E-01 |
Grade 2-vs-Grade 4 |
5.595800E-01 |
Grade 3-vs-Grade 4 |
2.007000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.58620003190657E-09 |
Normal-vs-ccB subtype |
1.199400E-03 |
ccA subtype-vs-ccB subtype |
3.585900E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
9.25590004641208E-09 |
Normal-vs-N1 |
1.380420E-01 |
N0-vs-N1 |
6.477000E-01 |
|
|